Abeona Therapeutics Inc. financial data

Symbol
ABEO on Nasdaq
Location
6555 Carnegie Ave, 4 Th Floor, Cleveland, OH
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 698 % +17.2%
Debt-to-equity 63.2 % -70.6%
Return On Equity 78.4 %
Return On Assets 48 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.2M shares +24.7%
Common Stock, Shares, Outstanding 52.4M shares +20.7%
Entity Public Float 171M USD +118%
Common Stock, Value, Issued 524K USD +20.7%
Weighted Average Number of Shares Outstanding, Basic 54.2M shares +12.8%
Weighted Average Number of Shares Outstanding, Diluted 54.2M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 400K USD
Research and Development Expense 29.1M USD -11.2%
General and Administrative Expense 32.5M USD +46.9%
Costs and Expenses 24M USD +56.5%
Operating Income (Loss) -83.2M USD -37%
Nonoperating Income (Expense) 1.02M USD +37.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.4M USD +32.7%
Income Tax Expense (Benefit) -15.2M USD
Net Income (Loss) Attributable to Parent 82.4M USD +83%
Earnings Per Share, Basic 1 USD/shares +84.1%
Earnings Per Share, Diluted 1 USD/shares +84.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 82.9M USD +427%
Cash, Cash Equivalents, and Short-term Investments 84.5M USD +34.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.5M USD +250%
Inventory, Net 4.85M USD
Assets, Current 216M USD +91.8%
Property, Plant and Equipment, Net 10.3M USD +155%
Operating Lease, Right-of-Use Asset 4.09M USD +7.84%
Other Assets, Noncurrent 541K USD +515%
Assets 231M USD +91.6%
Accounts Payable, Current 5.93M USD +113%
Accrued Liabilities, Current 6.89M USD +32.2%
Liabilities, Current 22.2M USD +20.4%
Operating Lease, Liability, Noncurrent 4.25M USD +25%
Liabilities 59.9M USD -20%
Accumulated Other Comprehensive Income (Loss), Net of Tax 10K USD
Retained Earnings (Accumulated Deficit) -722M USD +10.2%
Stockholders' Equity Attributable to Parent 171M USD +274%
Liabilities and Equity 231M USD +91.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.4M USD -26.6%
Net Cash Provided by (Used in) Financing Activities 6.77M USD -73.4%
Net Cash Provided by (Used in) Investing Activities 4.21M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 52.4M shares +20.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.42M USD -341%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 83.2M USD +418%
Interest Paid, Excluding Capitalized Interest, Operating Activities 675K USD +11.2%
Deferred Tax Assets, Valuation Allowance 114M USD +4.97%
Deferred Tax Assets, Gross 114M USD +4.97%
Operating Lease, Liability 4.36M USD -2.31%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 1.4M USD +93.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 82.4M USD +83.1%
Lessee, Operating Lease, Liability, to be Paid 5.78M USD +6.76%
Property, Plant and Equipment, Gross 26.7M USD +44.3%
Operating Lease, Liability, Current 102K USD -90.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.3M USD +63.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 419K USD -50.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +28.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.43M USD +49%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.33M USD +64.2%
Deferred Tax Assets, Operating Loss Carryforwards 88.1M USD +11.9%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 15.2M USD
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.36M USD +64.9%
Additional Paid in Capital 892M USD +5.05%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 534K USD +8.76%
Share-based Payment Arrangement, Expense 10.2M USD +64.5%
Interest Expense 3.94M USD +21.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%